文献速递关节外科

症状性良性前列腺增生是男性关节置换术后假体周围感染的危险因素

Symptomatic Benign Prostatic Hyperplasia: A Risk Factor for Periprosthetic Joint Infection in Male Patients.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

该回顾性研究纳入2006年至2017年12902例接受初次或翻修全关节置换的男性患者,其中386例(3%)有症状性良性前列腺增生(BPH)。匹配分析显示症状性BPH组假体周围感染(PJI)率为7.9%,对照组为2.8%,多因素回归证实症状性BPH是PJI的独立危险因素(p=0.01)。

要点

  • 症状性BPH患者关节置换后PJI风险显著升高(7.9% vs 2.8%)。
  • 匹配变量后症状性BPH仍是PJI的独立危险因素(p=0.01)。
  • 该发现可能部分解释男性患者PJI率较高的原因。

核心结论

  • 症状性BPH患者行全关节置换术后发生PJI的风险高于对照患者。
  • 症状性BPH可能是男性患者PJI率较高的部分原因。

研究设计与样本

  • 回顾性识别2006年1月至2017年4月共12902例接受初次或翻修全关节置换的男性患者。
  • 平均年龄62.47岁,平均体重指数30.1 kg/m²,多数为白种人或非裔美国人。
  • 手术以髋关节为主(57.8%),初次置换占86%。
  • 386例(3%)有症状性BPH,其中250例与708例对照按约1:3比例匹配。
  • 采用国际共识会议(ICM)标准判定PJI。

主要发现

  • 症状性BPH组PJI率为7.9%,对照组为2.8%。
  • 未匹配组多因素回归分析显示症状性BPH是PJI的强独立危险因素。
  • 匹配结局相关变量后,症状性BPH仍是PJI的显著危险因素(p=0.01)。

关键数值与推荐

  • PJI判定采用国际共识会议(ICM)标准。
  • 证据等级为预后Level III。

临床怎么用

  • 对拟行全关节置换的男性患者,应关注症状性BPH病史以评估PJI风险。
  • 症状性BPH患者围手术期可能需要更严格的感染预防与监测策略。

局限性

  • 本研究为回顾性设计,证据等级为Level III。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Male patients undergoing total joint arthroplasty have a higher risk of periprosthetic joint infection (PJI) compared with female patients. The exact reason for this finding is not well known. This study aimed to determine if patients with symptomatic benign prostatic hyperplasia (BPH) are at increased risk of PJI. METHODS: A total of 12,902 male patients who underwent primary or revision total joint arthroplasty from January 2006 to April 2017 were retrospectively identified. The mean patient age was 62.47 years and the mean patient body mass index was 30.1 kg/m. The majority of patients were Caucasian or African American. Most surgical procedures involved the hip joints (57.8%) and were primary arthroplasties (86%). Of these patients, 386 (3%) had symptomatic BPH. Among this group, 250 patients with symptomatic BPH were identified and were matched in an approximate 1:3 ratio with 708 control patients. Using the International Consensus Meeting criteria, patients who developed PJI were identified. RESULTS: The PJI rate was 7.9% in the symptomatic BPH group and 2.8% in the control group. Multivariate regression analysis in unmatched groups showed that symptomatic BPH was a strong independent risk factor for PJI. After matching for variables related to outcomes, symptomatic BPH remained a significant risk factor for PJI (p = 0.01). CONCLUSIONS: Patients with symptomatic BPH had a higher risk of PJI compared with the control patients. This may partly explain the higher rate of PJI that is seen in male patients. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Yazdi H, Restrepo C, Foltz C, et al. Symptomatic Benign Prostatic Hyperplasia: A Risk Factor for Periprosthetic Joint Infection in Male Patients. J Bone Joint Surg Am. 2020. PMID: 32079872. doi:10.2106/JBJS.19.00865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。